Published in J Clin Endocrinol Metab on September 01, 1970
Thyroid eye disease. BMJ (1993) 1.79
Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci (2014) 1.03
Human fibrocytes coexpress thyroglobulin and thyrotropin receptor. Proc Natl Acad Sci U S A (2012) 0.97
Graves' ophthalmopathy. Can Med Assoc J (1981) 0.91
Thyroid carcinoma metastatic to the globe. Br J Ophthalmol (1979) 0.88
Ocular manifestations of Graves' disease: a review. J R Soc Med (1984) 0.88
Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy. Proc Natl Acad Sci U S A (1979) 0.87
TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy. Nat Rev Endocrinol (2015) 0.78
Guidance on That Damned Elusive Orbitopathy of Graves' Disease. Eur Thyroid J (2016) 0.75
Dysthyroid ophthalmopathy: an update. J Natl Med Assoc (1979) 0.75
Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy. Front Endocrinol (Lausanne) (2017) 0.75
Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int (1985) 4.76
Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology (1974) 1.92
Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr (1979) 1.67
Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab (1973) 1.66
Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (1990) 1.65
Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics (1965) 1.39
Reproducibility of thallium-201 myocardial imaging. Circulation (1977) 1.36
HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab (1974) 1.33
Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab (1967) 1.26
Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. J Nucl Med (1985) 1.08
Screening for bone metastases. Are only scans necessary? JAMA (1975) 1.06
Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J Clin Endocrinol Metab (1971) 1.06
Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res (1975) 1.05
Computed tomography in orbital pseudothumor (idiopathic orbital inflammation). Radiology (1976) 1.04
Review of a 5-year experience with the radiostrontium bone scintiscan. Calif Med (1972) 1.02
Allogeneic cytolysis of reconstituted membrane vesicles. Proc Natl Acad Sci U S A (1979) 0.98
Radioisotopic angiocardiography: findings in congenital heart disease. J Nucl Med (1972) 0.98
Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metab (1971) 0.97
Interpolative background subtraction. J Nucl Med (1976) 0.94
Distribution and fate of synthetic lipid vesicles in the mouse: a combined radionuclide and spin label study. Proc Natl Acad Sci U S A (1974) 0.93
Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab (1986) 0.91
The influence of lipid substitution on thyrotropin-receptor interactions in artificial vesicles. Endocrinology (1977) 0.91
Radioisotopic angiocardiography. Wide scope of applicability in diagnosis and evaluation of therapy in diseases of the heart and great vessels. Circulation (1971) 0.91
In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration. J Nucl Med (1975) 0.91
Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease. J Clin Endocrinol Metab (1973) 0.90
Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies. J Clin Endocrinol Metab (1970) 0.89
HL-A antigens in Japanese Patients with Graves' disease. Tissue Antigens (1975) 0.89
Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. Am J Cardiol (1977) 0.88
Unruptured aneurysm of the sinus of valsalva producing right ventricular outflow obstruction. Am J Med (1972) 0.88
Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci (1983) 0.88
Computed tomography in Graves' ophthalmopathy. Radiology (1976) 0.88
Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy. Proc Natl Acad Sci U S A (1979) 0.87
Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys (1980) 0.87
Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa and anti-lambda antisera. J Clin Endocrinol Metab (1968) 0.85
Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum. J Clin Endocrinol Metab (1977) 0.85
Sounding board: On white coats and other matters. N Engl J Med (1975) 0.85
The long-acting thyroid stimulator and thyroid disease. Adv Intern Med (1970) 0.84
The diagnosis of intracardiac metastasis of colon carcinoma by radioisotopic and roentgenographic studies. Am J Cardiol (1970) 0.83
Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera. J Clin Endocrinol Metab (1979) 0.83
Helper and suppressor activities of lymphocyte subsets on antithyroglobulin production in vitro. J Clin Endocrinol Metab (1985) 0.82
Tc99m labelled toluidine blue O for liver scintillography. Int J Appl Radiat Isot (1968) 0.81
Purification of human anti-thyroglobulin. J Clin Endocrinol Metab (1975) 0.81
Combined superior vena cava obstruction and pericardial effusion demonstrated by radioisotopic angiocardiography. J Nucl Med (1970) 0.80
Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys (1985) 0.80
Peripheral blood lymphocytes from normal individuals can be induced to secrete immunoglobulin G antibodies against self-antigen thyroglobulin in vitro. J Clin Endocrinol Metab (1985) 0.79
In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids. J Clin Invest (1968) 0.79
Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases. J Clin Endocrinol Metab (1982) 0.79
Radioisotopic angiocardiography. Preoperative and postoperative evaluation of patients with diseases of the heart and aorta. Radiol Clin North Am (1971) 0.79
Vesicle interactions with polyamino acids and antibody: in vitro and in vivo studies. J Nucl Med (1975) 0.78
A solid phase, sandwich-type radioimmunoassay for antithyroglobulin: elimination of false positive results and semiquantitative measurement of antithyroglobulin in the presence of elevated thyroglobulin. J Clin Endocrinol Metab (1979) 0.78
Distribution and scintiphotography of a new complex, pentavalent technetium-99m citrate: studies in the rodent. J Nucl Med (1967) 0.78
Therapy with occlusive dressings of pretibial myxedema with fluocinolone acetonide. J Clin Endocrinol Metab (1967) 0.77
New thoughts about the cause and treatment of the severe ocular manifestations of Graves' disease. Scott Med J (1974) 0.77
Alteration of mammalian cells by interaction with artificial lipid vesicles. Cancer Res (1976) 0.77
Gallium-67 citrate scanning in Hodgkin's disease and non-Hodgkin's lymphoma. Cancer (1976) 0.76
The long-acting thyroid stimulator. Calif Med (1968) 0.76
Editorial: Hyperthyroidism. Calif Med (1970) 0.75
Treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J (1979) 0.75
Simple evaluation of thyroid function. West J Med (1988) 0.75
Diagnosis of pericardial effusion by radioisotopic angiocardiography. J Nucl Med (1969) 0.75
Diagnosis of congenital and acquired cardiovascular diseases by radioisotopic angiocardiography. Trans Assoc Am Physicians (1969) 0.75
Studies of radiopharmaceutical-enclosing lipid-protein vesicles formed from native plasma components. J Nucl Med (1977) 0.75
Video instrumentation for radionuclide angiocardiography. Am J Cardiol (1973) 0.75
Vesicle interactions with antibody and peptide hormone: role of vesicle composition. J Nucl Med (1976) 0.75
Guidelines and criteria for a committee authorizing the use of radioactive isotopes in humans. J Nucl Med (1967) 0.75
Preparation and binding of antimicrosomal antibody-free LATS, and the effect of iodination on LATS biological activity. J Clin Endocrinol Metab (1971) 0.75
An improved assay for thyrotropin-binding blocking activity in serum of patients with Graves' disease. J Endocrinol Invest (1984) 0.75
[Proceedings: Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex with the membrane fraction of the extraocular muscle]. Nihon Naibunpi Gakkai Zasshi (1974) 0.75
Degradation of C14-labeled thymidine and its halogenated analogues in man. Adv Tracer Methodol (1966) 0.75
Acute intracardiac volume changes demonstrated with radioisotopic angiocardiography. J Thorac Cardiovasc Surg (1972) 0.75
Scintiphotographic studies of acquired cardiovascular disease. Semin Nucl Med (1973) 0.75
A study of o-cresolphthalexon and its analogs as cholescintigraphic 111In carriers. Invest Radiol (1978) 0.75
Radioisotopic angiocardiography: findings in mitral stenosis and mitral insufficiency. J Nucl Med (1970) 0.75
Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates. Endocrinology (1977) 0.75
Letter: Orbital radiotherapy for the ophthalmopathy of Graves's disease. N Engl J Med (1974) 0.75
Albumin-loading effect: a pitfall in saline paper analysis of 99mTc-albumin. J Nucl Med (1974) 0.75
Congressional Image of NIH. Science (1963) 0.75
Technetium-99m(V)-citrate complex for estimation of glomerular filtration rate. Nature (1967) 0.75
Indium bone marrow scintigraphy as an aid in selecting marrow biopsy sites for the evaluation of marrow elements in patients with lymphoma. Cancer (1976) 0.75
Robert Reid Newell, 1892-1965. J Nucl Med (1966) 0.75
Distribution and scintiphotography studies of 99mTc-iron colloid in the rabbit. J Nucl Med (1969) 0.75
Distribution and scintiphotography of a new lung-scanning agent, 99mTc-macroaggregated thionin: studies in the rodent. J Nucl Med (1969) 0.75
The accuracy of 111InCl3 as a bone marrow scanning agent. Radiology (1976) 0.75
HLA antigens in Japanese patients with Graves' disease and Hashimoto's disease [proceedings]. Diabete Metab (1976) 0.75
Biological activity of autoantibodies associated with Graves' dermopathy. J Clin Endocrinol Metab (1989) 0.75
Variable time-lapse videoscintiscope: a modification of the scintillation camera designed for rapid flow studies. J Nucl Med (1969) 0.75
Reliability and reproducibility of interpretation of 99mtechnetium pyrophosphate myocardial scintigrams. Clin Cardiol (1979) 0.75
Multiple left ventricular outflow obstructions. Aortic valvular and supravalvular stenosis and coarctation of the aorta. J Thorac Cardiovasc Surg (1972) 0.75
Radioisotopic coronary arteriography. Kaku Igaku (1972) 0.75
Selective, symmetric, skeletal muscle uptake of Tc-99m pyrophosphate in rhabdomyolysis. Clin Nucl Med (1985) 0.75
A method to optimise the use of a grayshade scale in nuclear medicine images. Comput Biomed Res (1976) 0.75
Lipid vesicle interaction with EMT-6 tumor cells and effect on subsequent cell growth. Biochem Biophys Res Commun (1976) 0.75